Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for RedHill Biopharma (RDHL) over the last 14 years, with Q2 2025 value amounting to $18.0 million.

  • RedHill Biopharma's Shares Outstanding (Weighted Average) rose 5331.04% to $18.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.0 million, marking a year-over-year increase of 5331.04%. This contributed to the annual value of $260000.0 for FY2017, which is 833.33% up from last year.
  • Latest data reveals that RedHill Biopharma reported Shares Outstanding (Weighted Average) of $18.0 million as of Q2 2025, which was up 5331.04% from $11.8 million recorded in Q2 2024.
  • In the past 5 years, RedHill Biopharma's Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q2 2023 and a low of $11.8 million during Q2 2024
  • For the 5-year period, RedHill Biopharma's Shares Outstanding (Weighted Average) averaged around $464.8 million, with its median value being $467.4 million (2021).
  • As far as peak fluctuations go, RedHill Biopharma's Shares Outstanding (Weighted Average) surged by 13378.95% in 2023, and later crashed by 9907.97% in 2024.
  • Over the past 5 years, RedHill Biopharma's Shares Outstanding (Weighted Average) (Quarter) stood at $467.9 million in 2021, then grew by 16.82% to $546.6 million in 2022, then skyrocketed by 133.79% to $1.3 billion in 2023, then crashed by 99.08% to $11.8 million in 2024, then surged by 53.31% to $18.0 million in 2025.
  • Its last three reported values are $18.0 million in Q2 2025, $11.8 million for Q2 2024, and $1.3 billion during Q2 2023.